The effects of metabolic syndrome versus infectious burden on inflammation, severity of coronary atherosclerosis, and major adverse cardiovascular events

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 7, 2007, Pages 2532-2537

  Dai, Dao Fu ^a   Lin, Jou Wei ^a   Kao, Jia Horng ^a,b   Hsu, Chih Neng ^a   Chiang, Fu Tien ^a   Lin, Jiunn Lee ^a   Chou, Yi Hua ^a   Hsu, Kwan Lih ^a   Tseng, Chuen Den ^a   Tseng, Yung Zu ^a   Hwang, Juey Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HUMAN; INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

EID: 34447120214     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2428     Document Type: Article

References (35)

1. Libby P 2002 Inflammation in atherosclerosis. Nature 420:868-874
2. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y, Bernardes-Silva M, Ward M 2000 Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 321:208-213
3. LaBiche R, Koziol D, Quinn TC, Gaydos C, Azhar S, Ketron G, Sood S, DeGraba TJ 2001 Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 32:855-860
4. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, Willeit J 2001 Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 103:1064-1070
5. Danesh J, Youngman L, Clark S, Parish S, Peto R, Collins R 1999 Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ 319:1157-1162
6. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE 2001 Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32:385-391
7. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q 2000 Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102:833-839
8. Shi Y, Tokunaga O 2002 Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int 52:31-39
9. Alber DG, Powell KL, Vallance P, Goodwin DA, Grahame-Clarke C 2000 Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation 102:779-785
10. Sorlie PD, Nieto FJ, Adam E, Folsom AR, Shahar E, Massing M 2000 A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med 160:2027-2032
11. Ishizaka N, Ishizaka Y, Takahashi E, Toda EE, Hashimoto H, Ohno M, Nagai R, Yamakado M 2002 Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation 105:1028-1030
12. Ishizaka Y, Ishizaka N, Takahashi E, Unuma T, Tooda E, Hashimoto H, Nagai R, Yamakado M 2003 Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J 67:26-30
13. Zhu J, Quyyumi AA, Norman JE, Costello R, Csako G, Epstein SE 2000 The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis 182:1583-1587
14. Volzke H, Schwahn C, Wolff B, Mentel R, Robinson DM, Kleine V, Felix SB, John U 2004 Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 174:99-103
15. Tsai CT, Kao JH, Hsu KL, Chiang FT, Tseng CD, Liau CS, Tseng YZ, Hwang JJ 2001 Relation of Chlamydia pneumoniae infection in Taiwan to angiographically demonstrated coronary artery disease and to the presence of acute myocardial infarction or unstable angina pectoris. Am J Cardiol 88:960-963
16. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, Yoshizumi M, Kambe M 2005 Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 45:1219-1222
17. Videm V, Wiseth R, Gunnes S, Madsen HO, Garred P 2007 Multiple inflammatory markers in patients with significant coronary artery disease. Int J Cardiol 118:81-87
18. Kaklikkaya I, Kaklikkaya N, Buruk K, Pulathan Z, Koramaz I, Aydin F, Tosun I, Osman Kilic A, Ozcan F 2006 Investigation of Chlamydia pneumoniae DNA, chlamydial lipopolisaccharide antigens, and Helicobacter pylori DNA in atherosclerotic plaques of patients with aortoiliac occlusive disease. Cardiovasc Pathol 15:105-109
19. Schlitt A, Blankenberg S, Weise K, Gartner BC, Mehrer T, Peetz D, Meyer J, Darius H, Rupprecht HJ 2005 Herpesvirus DNA (Epstein-Barr virus, herpes simplex virus, cytomegalovirus) in circulating monocytes of patients with coronary artery disease. Acta Cardiol 60:605-610
20. Yang KC, Chen MF, Su TC, Jeng JS, Hwang BS, Lin LY, Liau CS, Lee YT, Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese. Atherosclerosis, in press
21. Tong DY, Wang XH, Xu CF, Yang YZ, Xiong SD 2005 Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol 11:1292-1296
22. Arcari CM, Nelson KE, Netski DM, Nieto FJ, Gaydos CA 2006 No association between hepatitis C virus seropositivity and acute myocardial infarction. Clin Infect Dis 43:e53-e56
23. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J 2002 Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105:15-21
24. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, Schlumberger W, Meyer J 2001 Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 104:25-31
25. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA 2002 Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 106:184-190
26. Rothenbacher D, Brenner H, Hoffmeister A, Mertens T, Persson K, Koenig W 2003 Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: role of confounding and reference group. Atherosclerosis 170:339-345
27. Khairy P, Rinfret S, Tardif JC, Marchand R, Shapiro S, Brophy J, Dupuis J 2003 Absence of association between infectious agents and endothelial function in healthy young men. Circulation 107:1966-1971
28. Ridker PM, Buring JE, Cook NR, Rifai N 2003 C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107:391-397
29. Girman CJ, Rhodes T, Mercuri M, Pyorala K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M 2004 The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/Tex-CAPS). Am J Cardiol 93:136-141
30. Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, Levesque S, Varga S 2004 Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 93:159-164
31. Anuurad E, Shiwaku K, Nogi A, Kitajima K, Enkhmaa B, Shimono K, Yamane Y 2003 The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health 45:335-343
32. Ringqvist I, Fisher LD, Mock M, Davis KB, Wedel H, Chaitman BR, Passamani E, Russell Jr RO, Alderman EL, Kouchoukas NT, Kaiser GC, Ryan TJ, Killip T, Fray D 1983 Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest 71:1854-1866
33. Auer J, Leitinger M, Berent R, Prammer W, Weber T, Lassnig E, Eber B 2003 Hepatitis A IgG seropositivity and coronary atherosclerosis assessed by angiography. Int J Cardiol 90:175-179
34. Epstein SE, Zhou YF, Zhu J 1999 Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100:e20-e28
35. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS 2004 Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation 109:42-46